| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Focuses on how cells acquire stable identities and diverge into distinct lineages during development. Includes potency transitions, germ-layer specification, differentiation hierarchies, lineage segregation, asymmetric division, and regulatory determinants of cell identity. Excludes post-developmental plasticity, mature-cell physiology, and evolutionary comparisons unless directly tied to developmental lineage specification. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates at single-cell and tissue scales, with temporal dynamics from minutes (asymmetric division cues) to hours/days (differentiation decisions) to embryonic/organismal timescales across developmental stages. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Stem cells, progenitors, differentiated lineages, transcription factors, signaling gradients, fate determinants, lineage trees, regulatory networks, chromatin states, asymmetric cell-division machinery. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Potency levels, gene-expression states, chromatin accessibility, signaling responsiveness, lineage biases, epigenetic marks, regulatory thresholds, positional identity, time-dependent competence windows. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Fate states (pluripotent, multipotent, progenitor, terminal), signaling modes (autocrine, paracrine, juxtacrine), lineage-branching patterns, regulatory categories (master regulators, modulators), division types (symmetric vs asymmetric), specification strategies (deterministic vs stochastic). |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Expression levels of key transcription factors, chromatin modification profiles, signaling pathway activity, positional coordinates, lineage-branch probabilities, potency-state metrics, cell-cycle phase dependency in lineage commitment. |
| | Parameterization | How variables encode and represent the system’s state. | System state encoded by regulatory-state vectors, gene-expression matrices, chromatin-accessibility maps, lineage-probability distributions, fate-transition graphs, and time-resolved signaling profiles. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating potency states as discrete; reducing regulatory networks to a small set of master factors; ignoring noisy fluctuations; assuming symmetric competence within populations; modeling fate choice as switch-like; neglecting mechanical or metabolic influences. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Breaks down when fate decisions involve graded, stochastic, or reversible processes; under heterogeneous microenvironments; when mechanical cues shape fate; in lineages with complex feedback; or when epigenetic landscapes change dynamically. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Fate decisions are governed by regulatory networks; lineage commitment emerges from integrated signaling and transcriptional inputs; asymmetric distribution of determinants influences daughter-cell identity; chromatin state constrains accessible lineage trajectories. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes regulatory networks remain stable enough to define identity, signaling gradients reliably specify positional information, lineage trees are reconstructable, and stochastic fluctuations do not overwhelm the developmental program. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Regulatory networks, signaling gradients, chromatin states, and lineage-branching logic must align; potency transitions must be compatible with observed lineage hierarchies and differentiation outcomes. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Fate states, determinants, signaling pathways, transcription factors, and epigenetic constraints must integrate into one coherent model describing stable lineage specification across developmental stages. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Changes in transcription-factor expression, shifts in chromatin accessibility, asymmetric segregation of determinants, lineage branching events, potency-state transitions, signaling-gradient responsiveness, and differentiation markers across developmental time. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by resolution of imaging and sequencing technologies, low-abundance factor detection thresholds, inability to observe rapid or transient fate-determining events, and challenges in measuring early embryo cells without perturbation. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Gene-expression levels, fluorescence intensity, chromatin-accessibility units, signaling-activity scores, lineage trace frequencies, potency metrics, spatial position (µm), temporal resolution (minutes–hours). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Confocal and light-sheet microscopes, single-cell RNA-seq platforms, ATAC-seq, ChIP-seq, lineage-tracing reporters, genetic barcoding systems, live-cell fate sensors, spatial transcriptomics, flow cytometers. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Fate state defined by stable transcription-factor combinations; potency defined by number of accessible lineages; lineage relationship defined by shared ancestry via tracing; asymmetric division defined by unequal determinant distribution; specification defined by irreversible fate bias. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Single-cell sampling, lineage tracing, live imaging of asymmetric division, barcoding and clonal reconstruction, quantifying expression signatures, mapping chromatin landscapes, measuring signaling-gradient responses. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Standardized embryo staging, consistent imaging conditions, balanced sampling across developmental windows, replicated single-cell sequencing runs, validated lineage-labeling strategies, controlled microenvironments for signaling measurements. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Sampling across multiple developmental timepoints, across distinct embryonic regions, across clonal lineages, and across differentiation states; avoiding bias toward abundant cell types; capturing rare early-fate events. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Single-cell transcriptomes, chromatin-accessibility matrices, lineage trees, live-imaging sequences, fate-marker expression maps, clonal barcoding trajectories, spatial gene-expression grids, signaling-response curves. |
| | Resolution | The granularity or precision with which data is captured. | Determined by sequencing depth, imaging resolution, temporal sampling frequency, lineage-tracing granularity, chromatin profiling sensitivity, and the ability to resolve sublineage heterogeneity. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Fluorescence calibration, reporter-signal normalization, sequencing-depth correction, lineage-tracing barcode-validation, spatial-alignment calibration, batch-effect normalization, and assay-specific QC procedures. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Identifying noise from stochastic gene expression, imaging drift, incomplete lineage labeling, sequencing dropout, mis-segmentation of cells, temporal undersampling of rapid fate transitions, and distinguishing technical noise from biological heterogeneity. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Fate decisions follow stable regulatory rules: specific transcription-factor combinations reliably commit cells to defined lineages; asymmetric segregation of determinants drives reproducible daughter-cell identities; signaling thresholds predict fate boundaries; lineage trees exhibit hierarchical, branching organization. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Core transcription-factor networks remain conserved across individuals and species; potency transitions follow ordered progressions; key signaling pathways (Wnt, Notch, Hedgehog) exhibit invariant roles in specification; asymmetric division mechanics follow conserved polarity and determinant-sorting rules. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Regulatory circuits stabilize fate; transcription-factor cross-repression locks in lineage choices; morphogen signaling gradients impose positional identity; epigenetic modifications reinforce gene-expression states; asymmetric division partitions fate determinants; feedback loops drive irreversible commitment. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Signal detection → transcription-factor activation → chromatin remodeling → lineage bias → stable fate commitment; polarity establishment → determinant segregation → daughter-cell divergence; morphogen gradient → threshold response → spatially patterned specification. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Potency, lineage commitment, specification, determination, differentiation, regulatory networks, morphogen thresholds, epigenetic stabilization, asymmetric division, lineage priming, competence windows. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Fate states (pluripotent, multipotent, progenitor, terminal), division types (symmetric vs asymmetric), specification modes (autonomous, conditional), regulatory-factor types (master regulators, modulators), lineage-tree architectures (binary, multi-branch, stochastic). |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Gene-regulatory network equations (ODE systems), morphogen-gradient diffusion equations, bistable switch models for fate commitment, threshold-response functions, stochastic models for noisy lineage decisions, epigenetic-state transition equations. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | GRN (gene-regulatory network) models, Waddington epigenetic-landscape models, bistable/multistable dynamical-systems models, agent-based lineage simulations, asymmetric-division models, potency-transition graphs. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Treating fates as discrete rather than continuous; reducing GRNs to binary switches; ignoring spatial heterogeneity; assuming morphogen gradients are smooth and stable; treating epigenetic landscapes as fixed; neglecting stochastic noise in decision thresholds. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Idealizations fail in systems with strong stochasticity, highly plastic lineages, rapidly shifting morphogen environments, mechanically induced fate transitions, dynamic chromatin landscapes, or heterogeneous signaling microenvironments. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Cell fate emerges from coordinated integration of signaling gradients, gene-regulatory networks, chromatin states, and asymmetric division; lineage specification is the convergence of positional information, intrinsic regulators, and epigenetic stabilization; Waddington’s landscape provides a unified conceptual scaffold. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to systems biology (network dynamics), epigenetics (chromatin landscapes), developmental signaling (morphogens), stem-cell biology (potency and renewal), biophysics (polarity mechanics), and evolutionary developmental biology (conserved regulatory modules). |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Perturbing transcription factors, altering morphogen gradients, manipulating chromatin regulators, inducing or blocking asymmetric division, engineering lineage reporters, modifying signaling pathways, and performing targeted ablations to test causal contributions to fate decisions. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Live imaging of spontaneous fate transitions, observing natural asymmetries in division, tracking endogenous clonal lineages, monitoring gene-expression fluctuations, and documenting fate patterning in unmanipulated embryos or organoids. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Testing whether specific transcription factors are necessary or sufficient for fate acquisition; evaluating morphogen-threshold models; validating lineage trees against clonal data; testing bistable-regulatory predictions; comparing predicted vs observed specification boundaries. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating lineage-tracing experiments, re-sequencing single-cell datasets, re-imaging developing tissues, independently validating chromatin-state changes, and testing fate determinants across multiple embryos or organoid systems. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Estimating fate-transition probabilities, reconstructing lineage trees, quantifying transcription-factor influence, modeling gene-expression noise, fitting GRN dynamics, and calculating uncertainty in lineage branching or commitment timing. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Comparing GRN models, bistable vs multistable systems, alternative morphogen-threshold models, stochastic vs deterministic fate-choice models, and epigenetic-state transition frameworks based on predictive accuracy and mechanistic coherence. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying segmentation errors in imaging, incorrect lineage reconstruction, sequencing dropouts, false-positive/negative fate markers, reporter instability, morphogen-measurement inaccuracies, and batch effects in epigenetic assays. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Standardizing imaging conditions, calibrating reporters, controlling microenvironmental variability, blinding lineage-scoring, using replicate embryos, verifying marker specificity, and applying normalization across sequencing batches. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Reanalyzing lineage maps, validating GRN predictions, reassessing morphogen models, checking epigenetic interpretations, cross-comparing datasets from different labs, and updating fate assignments when new evidence contradicts earlier lineage calls. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating regulatory-network topology, revising morphogen-threshold assumptions, incorporating new asymmetric-division mechanisms, adjusting fate-stability models, or adopting stochastic frameworks when deterministic ones fail. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full reporting of lineage-tracing constructs, imaging parameters, regulatory perturbations, computational pipelines, data normalization steps, and experimental limitations; making raw lineage and single-cell datasets available when possible. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Ethical handling of embryos or stem-cell systems, responsible genome editing, accurate representation of lineage trajectories, avoidance of selective reporting, and adherence to regulations for developmental-biology research. |